The MvaI RFLP was studied by polymerase chain reaction (PCR) amplification followed by MvaI restriction enzyme digestion, as previously described. The primer sequences used for PCR were MvaIDir (5-CTACCTAAGAGCTATCTACCGTTC-3) and MvaIRev (5-GGCTGTCCATGTTGTGGCTGC-3). For each reaction in 25 ml, 100 ng of DNA template was added to the reaction mixture, containing a final concentration of 200 nM of each primer, 200 mM of dNTPs, 1.5 mM MgCl2, 50 mM KCl, 10 mM Tris Cl (pH 8.5), and 1 U of Taq polymerase (Promega, Madison, WI, USA). The reaction wasQuadri RA and Proust JJ (2004) Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech. Ageing Dev. 126: 55-66.
Potestio M, Pawelec G, Di Lorenzo G, Candore G, D'Anna C, Gervasi F, Lio D, Tranchida G, Caruso C and Romano GC (2000) Age-related changes in the expression of CD95 (APO-1/FAS) on blood lymphocytes. Exp. Gerontol. 35: 1091-1103.
Gupta S (2005) Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine 23: 1567-1574.
Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M and Sansoni P (2000) Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging. Blood 95: 2860-2868.
Aggarwal S and Gupta S (2005) Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J. Immunol. 174: 2907-2915.
Huang R, Morrison-Bogorad M and Aloysius T (1999) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol. Immunol. 36: 485-493.
Huang R, Daniel BJ, Lasser R, Edmondson S and Aloysius T (1998) Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology 37: 1063-1068.
Huang R, Daniel BJ and Aloysius T (1998) Investigation of the polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification. Pathology 30: 47-51.
Bolstad AI, Wargelius A, Nakken B, Haga HJ and Jonsson R (2003) Fas and Fas Ligand gene polymorphisms in primary Sjogren's Syndrome. J. Rheumatol. 30: 1162-1166.
Gu W and Thompson EA (1992) Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48: 361-372.
Mariotti S, Sansoni P, Barbesino G, Caturegli P, Monti D, Cossarizza A, Giacomelli M, Passeri G, Fagioli U, Pinchera A and Franceschi C (1993) Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 342: 1480-1482.
Sansoni P, Cossarizza A, Brianti V, Fagnoni FF, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E, Fagiolo U, Passeri M and Franceschi C (1993) Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 82: 2767-2773.
Paganelli R, Scala E, Rosso R, Cossarizza A, Bertollo L, Barbieri D, Fabrizi A, Lusi EA, Fagiolo U and Franceschi C (1997) A shift to TH2-type cytokine production by CD4+ cells in human longevity: studies in two healthy centenarians. Eur. J. Immunol. 27: 1091-1095.
Cossarizza A, Ortolani C, Monti D and Franceschi C (1997) Cytometric analysis of immunosenescence. Cytometry 27: 297-313.
IVS3nt169FasL polymorphism typing Fagnoni FF, Vescovini R, Mazzola M, Bologna G, Nigro E, Lavagetto G, Franceschi C, Passeri M and Sansoni P (2000) Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians. Immunology 100: 495-503.
Pawelec G, Adibzadeh M, Rehbein A, Hahne M, Wagner W and Muller CA (1999TNF-alpha receptor expression and activation of caspases. J. Immunol.: Motta L, Receputo G, and Franceschi C for the Italian Multicentric Study on Centenarians. "I centenari in Italia: aspetti biologici e clinico-epidemiologici." In: Atti del Congresso della Società Italiana di Medicina Interna. Vol. X, pp. Y-Z (Roma: L. Pozzi Publ.). 

(Note: X, Y, and Z are placeholders for missing information that should be filled in with the correct data.)